Prominin-1 is a cell surface biomarker that allows the identification of stem and cancer stem cells from different organs. It is also expressed in several differentiated epithelial and nonepithelial cells. Irrespective of the cell type, prominin-1 is associated with plasma membrane protrusions. Here, we investigate its impact on the architecture of membrane protrusions using 
Prominin-1 is selectively enriched in protruding subdomains of the plasma membrane, such as microvilli and the primary cilium at the apical surface of epithelial cells. 7, 12, 13 It is also concentrated in stereocilia and motile cilia of the epididymis and endometrium, respectively. 3, 4 The specific subcellular localization of prominin-1 is likewise observed in non-epithelial cells, such as hematopoietic stem cells (HSCs). 1, 5, 14 Upon transfection of Chinese hamster ovary (CHO) cells, prominin-1 is strongly enriched in filopodia. 7 Furthermore, prominin-1 is released into various body fluids in association with small membrane vesicles. [15] [16] [17] [18] They originate from the tips of microvilli and cilia, where prominin-1 + budding structures were detected. 13, 19 These observations highlight the membrane dynamics of cellular protrusions.
Prominin-1 comprises five transmembrane segments that link an N-terminal extracellular domain, two short intracellular and two large glycosylated extracellular loops and an intracellular C-terminal domain. 7, 8 It is subjected to alternative splicing, which creates a substantial amount of splice variants. 2, 3, 20, 21 The functional significance of this variability is not yet understood. 22 At the molecular level, prominin-1 is associated with cholesteroldependent membrane micro/nanodomains (often referred to as lipid rafts). 23 Therein, it colocalizes with monosialotetrahexosylganglioside (GM 1 ), which is consistent with the presence of two gangliosidebinding sites in the sequence of prominin-1. [24] [25] [26] The direct binding of prominin-1 to membrane cholesterol determines its specific microvillar retention, and the cholesterol content regulates the shape of microvilli as well as the budding and fission of prominin-1 + vesicles thereof. 23, 27 In addition to the "lateral" binding of prominin-1 to membrane lipids, its "vertical" interactions are modulated by the phosphorylation of tyrosine residue 819 (referring to prominin-1 splice variant 1) by Src and Fyn tyrosine kinases. 28 Phosphorylated prominin-1 interacts with the 85-kDa regulatory subunit of phosphoinositide 3-kinase (PI3K) leading to the activation of PI3K/Akt pathway. 29 The locally activated PI3K can convert phosphatidylinositol(4, After two decades of research on prominin-1 its physiological function remains elusive. Retinal phenotypes in individuals carrying mutations in PROM1 gene and data from murine models hint to a scaffolding role of prominin-1 in the organization and dynamics of membrane protrusions emerging at the base of photoreceptor outer segment. 5, 22 The latter is a modified primary cilium. The absence of other major symptoms in patients or phenotypes of Prom-1 null mice can be explained, at least in part, by an upregulation of prominin-2 in tissues where both molecules are expressed. This is not the case in the retina. 19, [33] [34] [35] [36] [37] Prominins may constitute multivalent modules that, together with their interacting partners, could alter the membrane composition and/ or the organization of cellular protrusions. 12, [38] [39] [40] Here, we investigate this issue by creating specific mutations in prominin-1 that obstruct the interaction with its partners and study their impact on microvilli, which we use as a model of actin-driven membrane protrusions. 41 Microvilli consist of a bundle of parallel actin filaments that protrudes from the cell surface while its base is interconnected with a dense meshwork of actin and spectrin known as the terminal web. Our data suggest that the synergy of lipid/protein-prominin-1 complexes regulates the architecture and dynamics of cellular protrusions.
2 | RESULTS
| Distribution and morphology of microvilli at the apical plasma membrane
Prior to the analysis of the impact of prominin-1 on microvilli, we performed a high-resolution characterization of the apical membrane of polarized Madin-Darby canine kidney (MDCK) epithelial cells by scanning electron microscopy (SEM). At 6 days post-confluence (dpc), the distribution of microvilli varied considerably between neighboring cells ranging from densely packed to sparsely scattered ( Figure 1A ).
Microvilli were present as individual units or formed clusters comprising about 10 microvilli ( Figure 1A ). The mechanism underlying the formation of microvillar clusters is poorly characterized. 42, 43 No microvillus was detected in the proximity of the primary cilium, while those at cell borders were arranged in an array ( Figure 1A ). Microvillar length differed from cell to cell and was categorized into short 
| Expression of human prominin-1 in epithelial cells
To study the influence of prominin-1 on microvilli we overexpressed two splice variants of human prominin-1 (s1 and s2) in MDCK cells.
They differ by the short facultative exon 3 in the extracellular Nterminal domain of splice variant s2 that encodes for nine amino acids (PETVILGLK; Figure 2A , red square). Although the function of these residues is unknown, they might interfere with the interaction between prominin-1 and the ganglioside GM 1 . As described by Taïeb et al, prominin-1 contains two glycosphingolipid-binding domains. 26 One is located in the N-terminal domain and is proposed to bind GM 1 ( Figure 2A , orange cylinder) while the other was found in the vicinity of the second transmembrane domain and interacts with GD 3 (Figure 2A , yellow cylinder). The GM 1 -binding site contains typical turn-inducing residues (here, Pro 37 and Gly 50 ) and an aromatic one (Tyr 41 ). The latter is surrounded by charged amino acids and exposed to the extracellular milieu ( Figure 2A and Figure S2A ; for details see Reference 26) . To determine the impact of this lipid-binding domain
on the function of prominin-1 we mutated two of the key residues (Pro 37 ! Ala and Tyr 41 ! Ser) in both splice variants ( Figure 2A ).
They were termed 2M mutants. These residues are conserved among other mammalian prominin-1 sequences ( Figure S2A ). Upon stable transfection, more than 85% of the cells of each cell line expressed the recombinant protein as determined by flow cytometry ( Figure S3A ) with comparable expression levels as observed by immunoblotting ( Figure 2B and Figure S3B ,C).
The localization of prominin-1 was then examined by double labeling with mouse monoclonal antibody (mAb) CD133/1 directed against human prominin-1 and fluorescent cholera toxin B subunit
conjugates that recognize ganglioside GM 1 . Confocal laser scanning microscopy (CLSM) analysis revealed the colocalization of both prominin-1 splice variants with GM 1 at the apical membrane ( Figure 2C , top panels and Figure S2B ), in agreement with our previous report. 25 The punctate pattern is characteristic for prominin-1 associated with microvilli. 23, 44 Both 2M mutants also colocalized with GM 1 indicating that the created point mutations did not interfere with the proper microvillar localization of prominin-1 ( Figure 2C , bottom panels and Figure S2B ).
| Prominin-1 and its mutants increase the number of microvilli
Does prominin-1 influence the architecture of microvilli? To address this question we analyzed the apical plasma membrane using transmission electron microscopy (TEM) and SEM. The analysis suggested that both splice variants of prominin-1, notably their 2M mutants, FIGURE 1 Distribution and morphology of microvilli at the apical plasma membrane. A-C, MDCK cells were grown for 6 dpc (A, B) or as indicated (C) and analyzed by SEM. The apical membrane harbored either densely packed or sparsely scattered microvilli or clusters of them. No microvillus was observed near the primary cilium (dotted line) while an array of microvilli was found at cell borders (A). Their lengths ranged from short (<200 nm, red) to intermediate (200-400 nm, blue) to long (>400 nm, yellow) (B). Membrane ruffles or branched microvilli were rarely seen.
Microvilli of neighboring cells showed distinct shapes (B, yellow dashed line). Some microvilli were pseudocolored to highlight the phenotype.
Percentages of cells harboring a given phenotype at the indicated time are shown in pie charts (C). Data were acquired from six (1-8 dpc) or three (12 dpc) independent experiments. At least 100 cells per experiment were evaluated. (Extended data are presented in Table S1 including mean AE SD.) Scale bars, 500 nm; except low power view (A, cell border), 5 μm Figure S2A .) The cytoplasmic Cterminal end contains a tyrosine residue (819 or 828 in splice variant s1 and s2, respectively) that upon phosphorylation (P) promotes the interaction with the p85 subunit of the PI3K. This residue was mutated (Tyr ! Phe). B, C, Cells expressing human wild-type (WT) prominin-1.s1, s2 or their corresponding 2M mutants were grown for 6 dpc. The expression of prominin-1.s1 and s2 was evaluated by immunoblotting using mAb 80B258 and normalized to β-actin (n.s., not significant; two-tailed unpaired Student's t-test, n = 6) (B). The mean AE SD are indicated.
(Expression levels of 2M mutants are presented in Figure S3 .) Cells were cell surface-labeled with AC133 mAb directed against prominin-1 and cholera toxin subunit B (recognizing GM 1 ) and analyzed by CLSM (C). Colocalization of WT prominin-1.s1 or its 2M mutant with GM 1 is indicated (arrowhead) and insets show an enlargement of the apical membrane (square). (Colocalization of WT prominin-1.s2 or its 2M mutant with GM 1 is displayed in Figure S2B .) Scale bars, 5 μm (C) increase the number of microvilli ( Figure 3A and Figure S4A ). Besides, we noticed the occurrence of intracellular multivesicular structures in cells expressing 2M mutants ( Figure 3A and Figure S4A , green asterisk Figure 3A , SEM top panels and Figure 3B ). Interestingly, mutations in the GM 1 -binding site further increased their number (see also Figure S4A Figure 3A , SEM bottom panels and Figure 3C ) and each of them comprised about 10 AE 3 microvilli ( Figure 3D ). On cells expressing prominin-1.s1 or s2, a significant increase in the number of clusters and microvilli per cluster was detected ( Figure 3C,D) . The 2M mutants did not exert further effect on microvillar clusters, but the number of microvilli per cluster was increased in prominin-1.s1 2M ( Figure 3C ,D).
| Prominin-1 alters the architecture of microvilli
During our EM investigations we recognized alterations in the shape of microvilli ( Figure 4A ,B and Figure S4A ), which prompted us to conduct a quantitative analysis. Using SEM, more than 500 cells per line were randomly picked and assigned to one of the following categories: short, intermediate, long, branched, knob-like/irregularly shaped microvilli or membrane ruffles ( Figure 4C and Table S2 ). About 25% of prominin-1 Table S2 .) Scale bars, 100 nm (A), 500 nm (B)
| PI3K inhibition reduces modified microvilli and restores vesicle release
We hypothesize that the overexpression of prominin-1.s1 or s2, and particularly the 2M mutants, may cause an activation of PI3K, which is an interacting partner of prominin-1. As a result PIP 2 might be converted into PIP 3 in the inner leaflet of the microvillar membrane.
Because scaffolding proteins bind to PIP 2 and physically couple the plasmalemma to actin filaments, the phospholipid conversion might ( Figure 6B and Table S3 ).
In 2M mutants-expressing cells treated with LY294002, the reduction of altered microvilli was reflected by a 3-5-fold increase in the release of prominin-1 + vesicles in comparison to DMSO alone ( Figure 6C ). No significant increase was observed in cells expressing wild-type prominin-1 ( Figure 6C ). Of note, DMSO caused the formation of short microvilli at the expense of intermediate ones ( Figure 6B and The entire pellets and 1/40 of cell lysates were analyzed by immunoblotting using antibodies against human prominin-1 and β-actin (A). The arrow and arrowhead indicate the plasma membrane and endoplasmic reticulum-associated forms of prominin-1, respectively. Molecular mass markers (kDa) are indicated. (The uncropped blots are presented in Figure S5 .) The release of prominin-1 + vesicles was quantified (B). Prominin-1 immunoreactivity associated with cell lysates, P1 and P2 fractions were combined as Cell fraction while materials found in P3 and P4 were referred to as Vesicle fraction. Eight independent experiments were performed. The mean AE SD are indicated. *P < 0.05; **P < 0.01 (two-tailed unpaired Student's t-test) Table S3 .) C, Release of prominin-1 + vesicles upon LY294002 treatment.
4 hours-conditioned media were collected, subjected to differential centrifugation and analyzed by immunoblotting for prominin-1 as described in Figure 5 . Prominin-1 immunoreactivity in Cell and Vesicle fractions was quantified. The data are presented as fold-change values relative to DMSO-treated cells (arbitrary setup to 1, red line). Four independent experiments were performed. The mean AE SD are indicated. *P < 0.05 (two-tailed unpaired Student's t-test). Scale bar, 500 nm vesicles, suggesting that the occurrence of short microvilli is not the result of extended release (data not shown, see below).
| Arp2/3 complex inhibition reduces modified microvilli
Using SEM micrographs, we evaluated the angle formed by two branching protrusions within a given microvillus. The observed angle of 64.7 AE 12.5 (n = 21) was highly reminiscent of the activity of Arp2/3 complex that choreographs the formation of branched actin networks. 45 To evaluate its role, we incubated 2M mutants-expressing cells for 16 hours with the Arp2/3 complex inhibitor CK-666 or its inactive analogue CK-689. 46 No differences were observed between cells treated with CK-689 or DMSO as control ( Figure 7A ,B). However, cells incubated with CK-666 showed a significant reduction of branched and knob-like microvilli, suggesting that the Arp2/3 complex is involved in the alteration of microvilli ( Figure 7A ,B and Table S4 ).
Given that the individual inhibition of PI3K and Arp2/3 complex impaired the formation of both branched and knob-like microvilli we evaluated the combined effect. The incubation of cells with LY294002 and CK-666 created a synergistic effect that almost abolished altered microvilli ( Figure 7A ,C and Table S5 ). The number of individual microvilli and clusters of them were also significantly reduced reaching a level comparable to wild-type cells under the same Figure 3B ). Scale bars, 500 nm conditions, whereas the number of microvilli per cluster remained similar ( Figure 7D-F) . Thus, the increased number of microvilli in cells expressing prominin-1 mutants can be explained by their morphological alteration, which might interfere with their turnover. The altered microvilli generated by the overexpression of wild-type prominin-1.s1
and s2 were also lost upon the combined inhibition of PI3K and Arp2/3 complex (Table S5) . Likewise, we detected a significant reduction in the number of microvillar clusters in non-transfected cells, which also suggests that their formation relies on the activity of PI3K
and Arp2/3 complex ( Figure 7E ). Collectively, these data suggest that the overexpression of wild-type prominin-1 as well as mutations in its GM 1 -binding site induce a crosstalk with the PI3K pathway and the Arp2/3 complex, and hence a remodeling of the actin cytoskeleton.
| Impaired prominin-1-PI3K interaction reduces altered microvilli and restores vesicle release
To evaluate the impact of direct interaction between prominin-1 and PI3K on microvillar structure, we generated an additional mutation in the 2M mutants at tyrosine 819/828 (with reference to prominin-1.s1
and s2, respectively; Figure 2A and Figure S2A ). This amino acid is found in a tyrosine phosphorylation consensus site
xxY, 28 which is conserved in all prominin-1 sequences reported so far 4C and 9B) . The additional Y819/828F mutation also restored the release of prominin-1 + vesicles ( Figure 9C ).
| Ubiquitination of prominin-1 and its interaction with syntenin-1 are stimulated in 2M mutants
As microvilli stability and/or dynamics are changed upon the mutations in prominin-1 we suspected that its recycling and degradation might be altered. 14,47 Therefore, we evaluated whether prominin-1 is subjected to ubiquitination and/or interacts with the adaptor protein syntenin-1. 16 Both, the ubiquitination of cell surface prominin-1 and its interaction with syntenin-1, were significantly increased in cells expressing 2M mutants suggesting that mutations in the gangliosidebinding site of prominin-1 can trigger its recycling. The additional Y819/828F mutation reduced both interactions ( Figure 8E,F) . In contrast, no interaction with ezrin, an adaptor protein of the ezrin/ radixin/moesin (ERM) family, was observed ( Figure 8E ), which is in line with our previous study. Table S6 ) and 14 dpc (Table S6) , which is a significant increase compared with control cells (P < 0.005). This suggests that the phosphorylation of prominin-1 and/or its interaction with PI3K affects the length of microvilli. Moreover, no altered microvilli were detected suggesting that the point mutation neutralizes the effect of prominin-1 overexpression. These data are in line with those obtained upon PI3K inhibition. Finally, the Y819/828F mutation did not stimulate the release of prominin-1 + vesicles, indicating that short microvilli are not the result of extensive membrane budding ( Figure 10D , see also Figure 5B ).
In sum, our data suggest that multiple interactions of phosphory- and their corresponding mutants (as indicated) were subjected to immunoisolation using magnetic beads conjugated to mAb AC133 (AC133) or anti-fluorescein isothiocyanate (FITC) antibody as negative control. Bound fractions were analyzed by immunoblotting using mAbs against either prominin-1 (80B258), phosphotyrosine (pY) (A) or ezrin (E) or antisera against p85 subunit of PI3K, Arp2, p34-Arc/ARPC2 (p34) subunit of Arp2/3 complex (C), syntenin-1 or ubiquitin (Ubi) (E). Unbound fraction (UF) of ezrin is shown. The ratios of pY (B), p85, Arp2 and p34-Arc/ARPC2 (D) or Ubi and syntenin-1 (F)/prominin-1 immunoreactivities were quantified. Three to six independent experiments were performed. The mean AE SD are indicated. The arrow and open arrowhead indicate the plasma membrane and endoplasmic reticulum-associated forms of prominin-1, respectively. Molecular mass markers (kDa) are indicated. (The uncropped blots are presented in Figure S5 .) *P < 0.05; **P < 0.01; ***P < 0.005 (two-tailed unpaired Student's t-test)
Moreover, filopodia of prominin-1.s2-transfected cells were often branched, and we observed the appearance of narrow, sheet-like structures morphologically similar to growth cones ( Figure 11A ,B, red asterisk). 48 Often, long filopodia emerged from the apex of these structures. Growth cone-like structures were barely detected in prominin-1-negative cells. Astonishingly, they were more abundant in prominin-1.s2 2M mutant-expressing cells and the length of filopodia was also further increased (5.52 AE 2.27 μm, n > 600). Cells expressing prominin-1.s2 2M Y828F developed numerous axial and radial filopo- 
| Silencing of prominin-1 alters microvilli of HSCs
All data presented above suggest that mutations in human prominin-1 influence the structure of microvilli and other membrane protrusions.
This prompted us to investigate the microvillar morphology of a new murine model (rd19) where a spontaneous mutation in Prom1 gene causes prominin-1 knockdown. 34 As demonstrated by immunoblotting, both N-glycosylated prominin-1 found in the kidney as well as its endo H-resistant or PNGase F-sensitive deglycosylated forms were not detected in rd19 mice ( Figure 12A ). TEM analyses of the kidney and duodenum revealed no major alterations of individual microvilli present in both epithelia ( Figure 12B ,C, respectively), which is in line with previous observations in another prominin-1 null mice. 37 The length, diameter and internal actin cytoskeleton of microvilli are not markedly affected by the lack of prominin-1 ( Figure 12C ). However, we observed budding-like structures at the basal part of microvilli more often in rd19 mice than in wild-type animals, where they were detected at the tip of microvilli ( Figure 12C , red and black arrows, respectively). The latter might generate extracellular membrane vesicles while the former can result in both, vesicles and branched microvilli. Interestingly, the organization of the apical cortex of certain rd19 duodenal cells seemed uneven, which led to the appearance of cluster of microvilli ( Figure 12D , dashed line) with fused and/or branched microvilli ( Figure 12D , asterisks, red dots). Although fused microvilli Given that MDCK cells express both canine prominin-1 and prominin-2 49 (K.T. and D.C., data not shown), we decided to study the consequences of the lack of human prominin-1 in HSCs. These cells express solely prominin-1.s2 7, 8 and, importantly, are devoid of prominin-2. 19, [33] [34] [35] [36] [37] To that end, primary human CD34 + HSCs were immunoisolated from patients and prominin-1 was knocked down using short interfering (si) RNA oligonucleotides as described previously. 50, 51 Cells were then cultured on primary mesenchymal stromal cells (MSCs), which were used as feeder cell layer. MSCs secreted various soluble factors, including stromal cell-derived factor-1, and thus mimic to a certain degree the physiological conditions associated with the bone marrow niche. 51 We have previously demonstrated that the silencing of prominin-1 did not affect the migration and general polarization of CD34 + HSCs, that is, the formation of the uropod at the rear and lamellipodia at the leading edge. 50 At that time, we did not determine the impact on microvillus-like structures, particularly those associated with the uropod where prominin-1 is concentrated. 51, 52 Strikingly, SEM analysis revealed that the number of microvillus-like per uropod was significantly reduced in cells treated with siRNA against prominin-1 in comparison to cells transfected with control-siRNA ( Figure 13A,B) . In contrast, the knockdown of CD82, a tetraspanin protein associated with the HSC-uropod, 52 did not affect microvilli found thereon ( Figure 13A ,C).
| DISCUSSION
In this study, we deciphered the impact of prominin-1 on the architecture of microvilli used as a model of actin-driven membrane protrusions. 53 Each microvillus contains an array of 20-30 parallel actin FIGURE 10 Mutating tyrosine 819/828 of prominin-1 shortens microvilli. A-D, MDCK cells expressing wild-type prominin-1.s1 or s2 or Y819/828F mutants were grown for 6 dpc and processed for CLSM (A) or SEM (B). Cell surface labeling was performed with AC133 mAb directed against prominin-1 and nuclei were counterstained with DAPI (A). Note that prominin-1 immunofluorescence appears narrower in Y819/828F mutant than in wild-type protein (A, yellow bars). SEM micrographs (B) were used to calculate the percentages of cells harboring a given microvillar phenotype (C). Data were acquired from four independent experiments and at least 100 cells per experiment were evaluated.
(Extended data are presented in Table S6 including mean AE SD.) 16 hours-conditioned media were collected, subjected to differential centrifugation and analyzed by immunoblotting for prominin-1 as described in Figure 5 . Prominin-1 immunoreactivity in Cell and Vesicle fractions was quantified (D). Five independent experiments were performed. The mean AE SD are indicated. Scale bars, 5 μm (A, left panels), 1 μm (A, right panels), 500 nm (B). E, Schematic representation of the impact of prominin-1 on microvilli. Plus and minus ends of actin filaments within a microvillus are indicated. Green arrow and STOP symbol indicate the elongation of actin filaments or its termination, respectively. Decoupling of the plasma membrane from the underlying actin filaments is indicated with red double-headed arrow filaments that provides structural support. Within a cell, microvilli are typically homogeneous in length and width. 54 For our investigations, we overexpressed two distinct splice variants of human prominin-1
and created mutations in their extra-and intracellular domains that would impede their interactions with ganglioside GM 1 (2M mutants) and PI3K (Y819/828F mutants), respectively. 
55-57
Two major phenotypes were observed: branched microvilli and irregular ones with a knob-like structure at the tip. Both are enhanced in cells expressing the 2M mutants. Concomitant with this, the release of prominin-1 + vesicles was impaired suggesting that the dynamics of microvilli were perturbed. 17, 27, 58 Although poorly characterized, branched microvilli have been described in the literature, for example, in rat mammary ascites adenocarcinoma cells, 59 human conjunctival epithelium 60, 61 and principal cells of rat epididymis. 62 They were also observed in diseases such as microscopic enteritis and celiac disease. 63 , 64 Burgess and Grey The observed knob-like phenotype of microvilli has been previously reported for endothelial cells of cerebral arteries from spontaneously hypertensive rats and upon the action of insulin on rat hepatocytes. 90, 91 The latter observation was related to PI3K activity. 92 The interaction of prominin-1 with the PI3K can explain the formation of knob-like microvilli, its link to the branching phenotype and the dynamics of vesicle release. Precisely, the microvillar membrane is 
| Plasmid construction
Expression plasmids (hprom-1.s1 and hprom-1. Cells expressing the neomycin resistance gene were selected by introducing 500 μg/mL of Geneticin (G418 Sulfate; Thermo Fisher Scientific) into the culture medium. After selection, cells were further expanded in a medium containing 250 μg/mL of the selective agent.
Note that the microvillar morphology did not change when cells were cultured in medium with 0.5 or 1 mM geneticin or without (data not shown). These data rule out a direct effect of the drug on polyphosphoinositides. 101, 102 To enrich MDCK and CHO cell populations expressing human prominin-1, cells were sorted using paramagnetic labeling with CD133
MicroBeads (CD133 MicroBead Kit, #130-097-049; Miltenyi Biotec) and LS columns. To enhance the expression of the transgene 10 mM sodium butyrate was added to the culture medium for 16 hours except for SEM and TEM analysis. 44 If not stated otherwise, cells were 
| Endoglycosidase digestion
Kidney lysates were prepared from adult wild-type or rd19 mice using Membranes were exposed to Amersham Hyperfilms ECL (GE Healthcare). Fiji was used for the quantification of immunoblotted materials. 103 Note that none of the current available antibodies directed against human or mouse prominin-1 cross-reacted with canine and/or hamster orthologs. saponin diluted in PBS containing 0.2% gelatin (blocking buffer IV) 104 for 20 minutes at RT prior to immunolabeling for prominin-1 (see above) and p34-Arc/ARPC2 subunit of Arp2/3 complex using rabbit antiserum (5 μg/mL; Merck). Primary antibodies were observed using Alexa Fluor 488-conjugated goat anti-mouse IgG 1 and Alexa Fluor 555-conjugated donkey anti-rabbit IgG. All antibodies were diluted in blocking buffer IV. In some experiments, nuclei were counterstained with 4 0 -6-diamidino-2-phenylindole (DAPI, 1 μg/mL; Sigma-Aldrich).
All samples were then washed three times in PBS containing 0.2% gelatin, two times in PBS and H 2 O and mounted in Mowiol 4.88 (Merck).
Cells seeded in eight-well chambers were not mounted, but directly observed at RT with a confocal Zeiss LSM 700 using ZEN software and a 100× 1.4 oil DIC Plan-Apochromat objective, 4× zoom ( Figure 2C and Figure S2B ) or a 63× 1.4 oil DIC Plan-Apochromat objective ( Figure 10A ). All figures were processed with Fiji. 103 For the length measurement of filopodia emerging from CHO cells, CLSM micrographs of prominin-1 and/or WGA staining were used. Only cells with spread morphology, and not those of a rounded shape, were taken into consideration. Note that we did not measure the absolute number of their length since they were often tilted.
Instead we measured their length from the tip to the planar cell surface with an angle of 90 (see cartoon in Figure 11A ). Adult mice, 4 to 9 months of age, were fixed by perfusion with 2% PFA, 2% glutaraldehyde in 0.12 M phosphate buffer at RT. Tissues were dissected and fixed in the same buffer overnight. After washing steps, the tissue was further dissected into small pieces, which were post-fixed in 1% aqueous osmium tetroxide, 1.5% potassium ferrocyanide for 1 hour at RT. Subsequent steps were performed as described above. Note that Epon replacement (Carl Roth) was used as of resin and embedding was performed in silicon molds.
| Transmission electron microscopy

| Scanning electron microscopy
Samples for SEM analysis were prepared as described. 19 Briefly, MDCK cells were grown on fibronectin-coated coverslips for the indicated periods and then fixed in 2% glutaraldehyde overnight at 4 C.
The HSC-MSC co-cultures were fixed in the same way. After dehydration in an acetone gradient (25%-100%) all samples were critical point dried in a CO 2 system (Critical Point Dryer CPD 300; Leica).
Samples were mounted on aluminum stubs, coated with gold (≈20 nm thickness) in a sputter coater (SCD 050; BAL-TEC GmbH) and examined with a SEM (JSM-7500F; JEOL). SEM micrographs were used for the quantification of microvilli of MDCK cells and HSCs.
| Statistical analysis
Statistical analyses were performed using Graph Pad Prism version 6.00 for Mac (Graph Pad Software; www.graphpad.com). Two-tailed unpaired Student's t-test was used for the analysis of the immunoreactivity ratio of prominin-1/β-actin or other antigens, the number of 
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